AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) had a loss and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 0.4%.
AVEO Pharmaceuticals, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased to $-0.69 in the quarter versus EPS of $-0.77 in the year-earlier quarter.
Revenue: Decreased 65.12% to $300,000 from the year-earlier quarter.
Actual vs. Wall St. Expectations: AVEO Pharmaceuticals, Inc. reported adjusted EPS loss of $0.69 per share. By that measure, the company beat the mean analyst estimate of $-0.72. It missed the average revenue estimate of $2.52 million.
Quoting Management: “AVEO has several key events ahead this year, including the May 2 ODAC review of our NDA for tivozanib for the treatment of patients with advanced renal cell carcinoma and our PDUFA target action date of July 28,” said Tuan Ha-Ngoc, president and chief executive officer of AVEO. “Our company, in collaboration with our partner Astellas, is preparing for these important milestones while continuing our launch readiness efforts in support of the potential launch of tivozanib in the second half of the year.”
Key Stats (on next page)…
Revenue decreased 98.07% from $15.53 million in the previous quarter. EPS decreased to $-0.69 in the quarter versus EPS of $-0.43 in the previous quarter.
Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.54 to a loss $0.62. For the current year, the average estimate has moved down from a loss of $1.99 to a loss of $2.51 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)